Search results
Results From The WOW.Com Content Network
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [ 4][ 5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to ...
By Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of kidney disease, the health ...
3 Largest selling pharmaceutical products of 2015. 4 Best selling pharmaceuticals of 2013. ... Novartis: Cancer: Jun-1909: Mon-20XX 98: Betaseron, Betaferon ...
Novartis Gene Therapies, until 2020 known as AveXis, is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in Dallas , Texas , United States in 2012 by John Carbona after reorganizing a company called BioLife Cell Bank founded by David Genecov and John Harkey.
Swiss drugmaker Novartis' Votrient is among the approved treatments for soft-tissue sarcoma, a group of cancers which incl (Reuters) -The U.S. Food and Drug Administration said on Friday it has ...
FRANKFURT (Reuters) -Novartis' generic-drugs unit Sandoz said on Monday it plans to launch a generic version of Johnson & Johnson's anti-inflammatory drug Stelara under a collaboration deal with ...
Pages in category "Drugs developed by Novartis" The following 53 pages are in this category, out of 53 total. This list may not reflect recent changes. A. Aliskiren;
(Reuters) -Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros ($2.9 billion), adding a promising rare bone-marrow cancer treatment ...